VPAC2 (vasoactive intestinal peptide receptor type 2) receptor deficient mice develop exacerbated experimental autoimmune encephalomyelitis with increased Th1/Th17 and reduced Th2/Treg responses - Normandie Université Access content directly
Journal Articles Brain, Behavior, and Immunity Year : 2014

VPAC2 (vasoactive intestinal peptide receptor type 2) receptor deficient mice develop exacerbated experimental autoimmune encephalomyelitis with increased Th1/Th17 and reduced Th2/Treg responses

Fichier principal
Vignette du fichier
Tan et al BBI 2015.pdf (1.1 Mo) Télécharger le fichier
Origin : Files produced by the author(s)
Loading...

Dates and versions

hal-02377405 , version 1 (23-11-2019)

Identifiers

  • HAL Id : hal-02377405 , version 1

Cite

Yossan-Var Tan, Catalina Abad, Yuqi Wang, Robert Lopez, James A Waschek. VPAC2 (vasoactive intestinal peptide receptor type 2) receptor deficient mice develop exacerbated experimental autoimmune encephalomyelitis with increased Th1/Th17 and reduced Th2/Treg responses. Brain, Behavior, and Immunity, 2014. ⟨hal-02377405⟩
65 View
87 Download

Share

Gmail Facebook X LinkedIn More